Hundreds of CEOs converged on Las Vegas this week to tackle chip, power and grid bottlenecks slowing the AI boom.

Link Cell Therapies began dosing patients with its logic-gated CAR-T therapy at MD Anderson and grew its Series A to $90 million.

A BMJ study found CTE in 215 of 235 donated NFL brains, while its maximum possible prevalence estimate was 97.7% and its conservative minimum across former players was 24.5%.

More than 7,000 people were expected in Downtown Pittsburgh this week for IROS, a gathering focused on robotics research and real-world use.

Drawdown Georgia's new guide aims to help residents ask the right questions as roughly 100 facilities already hum statewide.

The Santa Clara chipmaker is betting big on spatial AI with its acquisition of World Labs, developer of the Atlas world model.

MOSI's North Tampa campus turns into a week-long space camp October 4-10, capped by a Friday SkyWatch under the stars.

A federal jury sided with Nektar Therapeutics, finding Eli Lilly breached their rezpegaldesleukin licensing deal.

Water entered a clinical area through a ceiling at the University of Louisville dentistry school over the weekend, then reached clinics on the second and first floors through crawl spaces.

The Jersey City cybersecurity firm's 2024 funding round set off a wave of moves, including a CEO swap and a nine-figure acquisition.

Insight Partners and Salesforce Ventures back the AI sales-tax startup as California's SaaS tax deadline looms in January.

The crypto payments giant is buying a Salt Lake City-area broker-dealer handling $9 billion in private market trades.

Gates says people with bad intent, not runaway machines, pose AI's biggest near-term danger — and a kill switch alone won't stop it.